Qualisure was awarded a $295,000 Alberta Innovates AICE-Validate grant to support further development of Thyroid GuidePx™, the next phase of the Molecular deCodeR build, and market access work.
The AICE-Validate program is an opportunity for Alberta’s health-tech innovators to accelerate commercialization of digital and data-enabled health technologies. The AICE-Validate Program is designed to accelerate progression through the Health Innovation Cycle, from proof of feasibility to initial clinical validation.